Convertible note offering raises dilution risk: Can Axon stock hold $423.32 support?

Traders Union
All News
Stocks
Axon slides 3.4% to $452.43 today

Highlights

Axon Enterprise priced $1 billion in 0% convertible senior notes due 2031, raising net proceeds of roughly $986 million.
Some proceeds fund capped call transactions to reduce dilution risk, with the rest allocated to growth or strategic investments.
Shares of Axon traded down 3.4% and remain under selling pressure, with price expected between $423.32 to $481.54 over the next few days.

Dilution risk weighs on sentiment after $1 billion convertible note raise

Axon Enterprise priced $1 billion in 0% convertible senior notes due 2031, with an additional $150 million available through underwriters' options, and expects net proceeds of roughly $986 million, according to Tradingview. This capital raise increases Axon's cash reserves, with a portion allocated to capped call transactions aimed at limiting shareholder dilution, while remaining funds are slated for corporate projects, growth initiatives, or strategic investments. The note structure introduces future dilution risk for existing shareholders, which can weigh on sentiment as the market digests the potential impact on share value.

Bearish signals as price tests support and momentum weakens

On the H1 chart, AXON is trading below the MA-20 at $458.61 and MA-50 at $477.54, while the daily MA-200 sits above at $503.87. The Ichimoku Kijun level at $467.14 marks immediate resistance. Momentum readings remain negative, with MACD at Strong Sell and ADX signaling a Sell bias. RSI registers at 39.72, indicating slight oversold conditions, while Stoch RSI and CCI are both Neutral. Intraday, Bull/Bear Power confirms sellers' dominance and the Awesome Oscillator aligns with further downside risk.

Downside favored as low upside potential persists short term

Over the next 2–3 trading days, the expected price range for AXON is $423.32 to $481.54, reflecting typical volatility around current levels. The probability of a move to the upside is very low, while the likelihood of further declines remains high, making a short-term recovery less likely. If the price rises above the $467.14 resistance, short covering could trigger a rally; if support at $423.32 breaks, the stock may experience additional downside momentum.

Anton Kharitonov, expert at Traders Union, sees continued downside risk for Axon as technical signals stay negative and the convertible note issue weighs on sentiment. He believes the large capital raise amplifies dilution risks without immediate value creation, while the price remains pressured below key averages. The short-term setup skews defensive unless resistance at $467.14 is overcome. "With dilution concerns and weak momentum, I remain cautious unless the price can close above resistance."

Previously it was reported that Axon's $1 billion convertible note offering heightened selling pressure and drove the stock into a sustained downtrend. The current analysis reinforces this bearish outlook, with continued downside momentum and sellers' dominance suggesting traders should closely monitor the $423.32 support level for any signs of a reversal.

Source of Data: AXON Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.